Memantine vs Tofacitinib

## Memantine vs Tofacitinib: Overview

This comparison examines the pharmacological differences between **Memantine** and **Tofacitinib**.

## Mechanism of Action

**Memantine**: Non-competitive NMDA receptor antagonist.

**Tofacitinib**: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

## Pharmacokinetics

**Half-life**: Memantine — 60-80 hours; Tofacitinib — 3.2 hours.

## Chemical Properties

**Molecular Formula**: Memantine — C12H21N; Tofacitinib — C16H20N6O.

**Molecular Weight**: Memantine — 179.3080 g/mol; Tofacitinib — 312.3700 g/mol.

**Type**: Memantine — Small molecule; Tofacitinib — Small molecule.